109 related articles for article (PubMed ID: 36113980)
1. SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis.
Kulkarni AV; Metage CS; Gora BA; Tirumalle S; Rakam K; Satyavadi A; Sharma M; Shaik S; Gujjarlapudi D; Rao PN; Reddy DN
Gut; 2023 Oct; 72(10):1995-1996. PubMed ID: 36113980
[No Abstract] [Full Text] [Related]
2. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
[TBL] [Abstract][Full Text] [Related]
3. Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma.
Pazgan-Simon M; Kucharska M; Górka-Dynysiewicz J; Simon K
Pharmacol Rep; 2022 Dec; 74(6):1306-1314. PubMed ID: 36394820
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients.
Deng H; Lin H; Mai Y; Liu H; Chen W
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):933-939. PubMed ID: 35482929
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis.
John BV; Bastaich DR; Ferreira RD; Doshi A; Taddei TH; Kaplan DE; Spector S; Deng Y; Dahman B
Gut; 2023 Sep; 72(9):1800-1802. PubMed ID: 36562753
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2 infection in patients with a normal or abnormal liver.
Cabibbo G; Rizzo GEM; Stornello C; Craxì A
J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
[TBL] [Abstract][Full Text] [Related]
7. Paraviral cutaneous manifestations associated to SARS-CoV-2 Omicron variant.
Zupin L; Moltrasio C; Tricarico PM; Del Vecchio C; Fontana F; Marzano AV; Crovella S
Infect Dis (Lond); 2023 Mar; 55(3):181-188. PubMed ID: 36494183
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
9. Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.
Joung SY; Ebinger JE; Sun N; Liu Y; Wu M; Tang AB; Prostko JC; Frias EC; Stewart JL; Sobhani K; Cheng S
JAMA Netw Open; 2022 Aug; 5(8):e2227241. PubMed ID: 35976645
[TBL] [Abstract][Full Text] [Related]
10. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
11. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination.
Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L
World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.
Tang J; Novak T; Hecker J; Grubbs G; Zahra FT; Bellusci L; Pourhashemi S; Chou J; Moffitt K; Halasa NB; Schwartz SP; Walker TC; Tarquinio KM; Zinter MS; Staat MA; Gertz SJ; Cvijanovich NZ; Schuster JE; Loftis LL; Coates BM; Mack EH; Irby K; Fitzgerald JC; Rowan CM; Kong M; Flori HR; Maddux AB; Shein SL; Crandall H; Hume JR; Hobbs CV; Tremoulet AH; Shimizu C; Burns JC; Chen SR; Moon HK; Lange C; Randolph AG; Khurana S
Nat Commun; 2022 May; 13(1):2979. PubMed ID: 35624101
[TBL] [Abstract][Full Text] [Related]
13. Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.
Tsakok MT; Watson RA; Saujani SJ; Kong M; Xie C; Peschl H; Wing L; MacLeod FK; Shine B; Talbot NP; Benamore RE; Eyre DW; Gleeson F
Radiology; 2023 Jan; 306(1):261-269. PubMed ID: 35727150
[TBL] [Abstract][Full Text] [Related]
14. Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection.
Kim J; Seo H; Kim HW; Kim D; Kwon HJ; Kim YK
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366556
[TBL] [Abstract][Full Text] [Related]
15. Letter to the editor: Reactivation of HBV triggered by SARS-CoV-2 in a patient with cirrhosis.
Librero Jiménez M; López Garrido MÁ; Fernández Cano MC
Hepatology; 2022 Mar; 75(3):765-766. PubMed ID: 34888903
[No Abstract] [Full Text] [Related]
16. Impact of COVID-19 on pre-existing liver disease.
Abdo-Francis JM; Moreno-Alcantar R; Pérez-Hernández JL; Remes-Troche JM; Velasco AV; Cerda-Reyes E; Tijera FH; Castro-Narro G
Cir Cir; 2024; 92(1):131-136. PubMed ID: 38537242
[TBL] [Abstract][Full Text] [Related]
17. Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.
Portmann L; de Kraker MEA; Fröhlich G; Thiabaud A; Roelens M; Schreiber PW; Troillet N; Iten A; Widmer A; Harbarth S; Sommerstein R;
JAMA Netw Open; 2023 Feb; 6(2):e2255599. PubMed ID: 36790812
[TBL] [Abstract][Full Text] [Related]
18. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
20. [Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].
Yan Y; Lyu C; Davgadorj C; Wang X; Sha M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):32-36. PubMed ID: 36880235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
